| Medical therapy of acute myocardial infarction: Part II. The role of adjunctive medical therapy. | |
| | |
MedLine Citation:
|
PMID: 10155176 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The second part of this review summarizes the role of other classes of pharmacological therapy in treatment of acute myocardial infarction (MI). The goals of pharmacological therapy are to alleviate symptoms, to stabilize hemodynamic status, and to prevent arrhythmias. These agents have been utilized primarily because of their ability to limit infarct size. Other beneficial properties may include their effects on neurohormonal activation, hemodynamics, and arrhythmias. In an individual patient, age, associated medical conditions, and hemodynamic status are important considerations in choosing a specific class of drug therapy. The beta-adrenergic blocking agents have modest effects on mortality, and they are useful when used alone and in combination with thrombolytic agents. Calcium antagonists have a limited role in acute MI. Diltiazem reduces the incidence of reinfarction in patients with non-Q MI. Oral nitrate therapy has not been shown to reduce mortality. Data from recent trials suggest that prophylactic administration of antiarrhthymic therapy is also not useful in acute MI. The role of angiotensin-converting enzyme inhibitors when administered in the acute phase of MI needs to be evaluated further. These agents are safe and well tolerated, and they offer greatest benefit when given in patients with left ventricular dysfunction. |
| | |
Authors:
|
S M Jafri; S Borzak |
Related Documents
:
|
17406056 - Bax deficiency reduces infarct size and improves long-term function after myocardial in... 9887046 - Changes in cardiac ang ii postmyocardial infarction in rats: effects of nephrectomy and... 19710536 - Ribose treatment reduced the infarct size and improved heart function after myocardial ... 10536696 - Chronic high-dose creatine feeding does not attenuate left ventricular remodeling in ra... 18787446 - The use of natriuretic peptides in the intensive care unit. 2909566 - Prolonged abnormalities of left ventricular diastolic wall thinning in the "stunned" my... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of intensive care medicine Volume: 10 ISSN: 0885-0666 ISO Abbreviation: J Intensive Care Med Publication Date: 1995 May-Jun |
Date Detail:
|
Created Date: 1995-11-09 Completed Date: 1995-11-09 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 8610344 Medline TA: J Intensive Care Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 109-16 Citation Subset: T |
Affiliation:
|
Heart and Vascular Institute, Henry Ford Hospital, Detroit, MI 48202, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Adrenergic beta-Antagonists / therapeutic use Algorithms Angiotensin-Converting Enzyme Inhibitors / therapeutic use Anti-Arrhythmia Agents / therapeutic use Calcium Channel Blockers / therapeutic use Cardiovascular Agents / therapeutic use* Humans Magnesium / therapeutic use Myocardial Infarction / drug therapy* Nitrates / therapeutic use Thrombolytic Therapy |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Anti-Arrhythmia Agents; 0/Calcium Channel Blockers; 0/Cardiovascular Agents; 0/Nitrates; 7439-95-4/Magnesium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Current concepts in splenic trauma.
Next Document: Diagnosis and treatment of smoke inhalation.